The FDA has suggested an Indian API maker hire a consultant that understands FDA regulations after finding the company didn’t have a grasp of some basic requirements, including how to make sure the ...
In its third exit from an Indian portfolio company within a month, Asia focused hedge fund Steadview Capital has sold more stake in a publicly listed active pharmaceutical ingredients (API) maker.
A US state pension fund has invested in a Hyderabad-based active pharmaceutical ingredients (API) maker. This is the latest in a string of deals by investors in the Indian bulk drugs space as pharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results